Description

(4Z,7Z,10Z,13Z,16Z,19Z)-n-[(2R)-1-Hydroxypropan-2-Yl]Docosa-4,7,10,13,16,19-Hexaenamide is a high-purity, structured lipid derivative of docosahexaenoic acid (DHA) featuring a specific stereochemistry and amide linkage. This compound is of significant interest for advanced research and development in pharmaceutical and nutraceutical applications, particularly in the study of lipid signaling, neurochemistry, and targeted drug delivery systems. It is primarily utilized by R&D scientists and formulators in the life sciences sector seeking well-defined molecular tools for probing biological pathways and developing novel therapeutic agents.

Application

• Pharmaceutical Research: As a key intermediate or reference standard in the development of novel neuroprotective agents, anti-inflammatory drugs, and compounds targeting metabolic disorders.
• Nutraceutical Development: For the formulation of advanced dietary supplements and functional foods aimed at cognitive health and inflammatory response modulation, leveraging its DHA backbone.
• Biochemical Research: As a tool compound in studying lipid metabolism, cell membrane fluidity, and the role of specific polyunsaturated fatty acid amides in cellular signaling pathways.
• Drug Delivery Systems: Potential use as a lipid conjugate to enhance the bioavailability and targeted delivery of therapeutic molecules across biological barriers.
• Analytical Standard: Serves as a high-purity certified reference material (CRM) for quality control and method development in analytical laboratories using techniques like HPLC and LC-MS.
• Cosmeceutical Ingredients: Investigation into topical formulations for skin health, utilizing the potential anti-inflammatory and protective properties of structured lipid molecules.

Basic Information

Product Name	(4Z,7Z,10Z,13Z,16Z,19Z)-n-[(2R)-1-Hydroxypropan-2-Yl]Docosa-4,7,10,13,16,19-Hexaenamide
CAS No.	1282618-08-9
Molecular Formula	C25H39NO2
Molecular Weight	385.59 g/mol
Synonyms	DHA Ethanolamide Derivative; (R)-N-(1-Hydroxypropan-2-yl)docosa-4,7,10,13,16,19-hexaenamide; 2-Hydroxypropyl-DHA-amide; 4,7,10,13,16,19-Docosahexaenamide, N-[(1R)-1-hydroxy-2-propanyl]-; DHA-based Lipid Amide; N-[(2R)-1-Hydroxypropan-2-yl]docosa-4,7,10,13,16,19-hexaenamide; DHA Propanolamide; ω-3 Fatty Acid Ethanolamide Analog
EINECS	Contact for details

Quality Control

Our (4Z,7Z,10Z,13Z,16Z,19Z)-n-[(2R)-1-Hydroxypropan-2-Yl]Docosa-4,7,10,13,16,19-Hexaenamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, MS), to ensure it meets exacting research-grade specifications. Certificates of Analysis (COA) detailing batch-specific results are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below under an inert atmosphere (e.g., argon or nitrogen) to prevent oxidation. Allow the sealed container to reach room temperature before opening to minimize moisture condensation. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	Colorless to pale yellow oil
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Isomeric Purity (Chiral HPLC)	≥ 98.0% (R-configuration)
Heavy Metals	< 10 ppm
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.